Jonathan J. Darrow

Harvard Medical School

Faculty

25 Shattuck St

Boston, MA 02115

United States

  • Harvard Medical School

SCHOLARLY PAPERS

26

DOWNLOADS
Rank 5,229

SSRN RANKINGS

Top 5,229

in Total Papers Downloads

12,815

SSRN CITATIONS
Rank 34,944

SSRN RANKINGS

Top 34,944

in Total Papers Citations

12

CROSSREF CITATIONS

12

Scholarly Papers (26)

Actions:
Email selected abstracts
1.

Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs

Journal of Law, Medicine and Ethics, 2013, Vol. 14, No. 3: 590-610
Number of pages: 11 Posted: 20 Jun 2013 Last Revised: 11 Apr 2020
Donald W. Light, Joel Lexchin and Jonathan J. Darrow
Rowan University School of Osteopathic Medicine, York University and Harvard Medical School
Downloads 9,648 (931)
Citation 1

Abstract:

Loading...

2.

Social Networking Web Sites and the Dmca: A Safe-Harbor from Copyright Infringement Liability or the Perfect Storm?

NORTHWESTERN JOURNAL OF TECHNOLOGY & INTELLECTUAL PROPERTY, Vol. 6, No. 1, 2007
Number of pages: 36 Posted: 28 Oct 2010
Jonathan J. Darrow and Gerald Ferrera
Harvard Medical School and affiliation not provided to SSRN
Downloads 469 (98,814)

Abstract:

Loading...

DMCA, copyright, YouTube, Social Networking, digital

3.

Debunking the Evergreening Patents Myth

131(6) Harvard Law Record 6 (2010)
Number of pages: 2 Posted: 04 May 2012 Last Revised: 11 Aug 2021
Jonathan J. Darrow
Harvard Medical School
Downloads 457 (101,796)
Citation 1

Abstract:

Loading...

patents, drug, pharmaceutical, evergreen

4.

The Patentability of Enantiomers: Implications for the Pharmaceutical Industry

Stanford Technology Law Review, Vol. 2, 2007
Number of pages: 19 Posted: 29 Oct 2010
Jonathan J. Darrow
Harvard Medical School
Downloads 435 (108,016)

Abstract:

Loading...

patent, enantiomer, chiral, pharmaceutical, drug, isomer, obvious to try, obviousness

5.

Who Owns a Decedent’s E-Mails: Inheritable Probate Assets or Property of the Network?

NYU JOURNAL OF LEGISLATION & PUBLIC POLICY, Vol. 10, p. 281, 2007
Number of pages: 40 Posted: 28 Oct 2010
Jonathan J. Darrow and Gerald Ferrera
Harvard Medical School and affiliation not provided to SSRN
Downloads 216 (225,776)
Citation 1

Abstract:

Loading...

e-mail, copyright, inherit, probate, service provider, bailment

6.

The Search Engine Advertising Market: Lucrative Space or Trademark Liability?

Texas Intellectual Property Law Journal, Vol. 17, p. 223, Fall 2008
Number of pages: 45 Posted: 09 Nov 2010
Jonathan J. Darrow and Gerald Ferrera
Harvard Medical School and affiliation not provided to SSRN
Downloads 182 (263,589)

Abstract:

Loading...

7.

Essential Medicines: Why International Price Discrimination May Increasingly Be the Wrong Solution to a Global Drug Problem

Journal of Law, Medicine and Ethics, Vol. 39, p. 291, 2011
Number of pages: 11 Posted: 02 May 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 160 (294,439)

Abstract:

Loading...

Essential Medicines, Global Health, Price Discrimination, Differential Pricing, WHO, advance market commitments, Internet Arbitrage, pharmaceutical tourism, drug patents

8.

The Neglected Dimension of Patent Law's PHOSITA Standard

Harvard Journal of Law and Technology, Vol. 23, No. 1, 2009
Number of pages: 32 Posted: 03 May 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 124 (360,034)

Abstract:

Loading...

Patent, PHOSITA, "ordinary mechanic", KSR, invention

9.

Pharmaceutical Efficacy: The Illusory Legal Standard

Washington and Lee Law Review, Vol. 70, No. 4, 2013
Number of pages: 65 Posted: 28 Jan 2014
Jonathan J. Darrow
Harvard Medical School
Downloads 120 (368,803)
Citation 1

Abstract:

Loading...

pharmaceuticals, efficacy, safe and effective, FDA, FDCA, substantial evidence, gold standard, statistical significance

10.

An Exploration of Compulsory Licensing as an Effective Policy Tool for Antiretroviral Drugs in India

Health Matrix: Journal of Law-Medicine, Vol. 23, No. 2, 2013
Number of pages: 34 Posted: 28 Jan 2014
Dipika Jain and Jonathan J. Darrow
O. P. Jindal Global University - Jindal Global Law School (JGLS) and Harvard Medical School
Downloads 119 (371,138)

Abstract:

Loading...

Patent, Pharmaceutical, Essential Medicines, Compulsory Licensing, TRIPS, Intellectual Property

11.

Crowdsourcing Clinical Trials

Minnesota Law Review, Vol. 98, 805, 2014
Number of pages: 63 Posted: 28 Jan 2014
Jonathan J. Darrow
Harvard Medical School
Downloads 117 (375,615)

Abstract:

Loading...

Crowdsourcing, clinical trials, ethics, FDA, REMS, MedWatch, Sentinal, pharmaceuticals

12.

When Markets Fail: Patents and Infectious Disease Products

73(3) Food & Drug L J 361 (2018)
Number of pages: 26 Posted: 22 Aug 2019
Jonathan J. Darrow, Michael S. Sinha and Aaron S. Kesselheim
Harvard Medical School, Saint Louis University - School of Law and Brigham and Women's Hospital/Harvard Medical School
Downloads 115 (380,239)
Citation 2

Abstract:

Loading...

13.

Adverse Employment Consequences Triggered by Criminal Convictions: Recent Cases Interpret State Statutes Prohibiting Discrimination

Wake Forest Law Review, Vol. 42, 2007
Number of pages: 48 Posted: 02 May 2012
Jonathan J. Darrow and Christine O'Brien
Harvard Medical School and affiliation not provided to SSRN
Downloads 111 (390,074)

Abstract:

Loading...

14.

Secondary Considerations: A Structured Framework for Patent Analysis

Albany Law Review, Vol. 74, p. 47, 2012
Number of pages: 46 Posted: 04 May 2012 Last Revised: 31 Oct 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 84 (468,709)
Citation 1

Abstract:

Loading...

secondary considerations, secondary factors, objective indicia, obviousness, nonobviousness, patent, unexpected results, teaching away, Graham factors

15.

Employment Termination for Employee Blogging: Number One Tech Trend for 2005 and Beyond, or a Recipe for Getting Dooced?

UCLA Journal of Law and Technology, 2006
Number of pages: 49 Posted: 03 May 2012
Stephen Lichtenstein and Jonathan J. Darrow
Bentley University - Department of Law and Harvard Medical School
Downloads 75 (500,728)

Abstract:

Loading...

16.

'Do You Really Need My Social Security Number?' Data Collection Practices in the Digital Age

North Carolina Journal of Law and Technology, Vol. 10, No. 1, 2008
Number of pages: 58 Posted: 30 Oct 2010
Jonathan J. Darrow and Stephen Lichtenstein
Harvard Medical School and Bentley University - Department of Law
Downloads 71 (516,167)

Abstract:

Loading...

17.

Few New Drugs Deserve Expedited Regulatory Treatment

Jonathan J. Darrow, Few New Drugs Deserve Expedited Regulatory Treatment, Journal of Managed Care and Specialty Pharmacy (2021)
Number of pages: 7 Posted: 10 Mar 2021
Jonathan J. Darrow
Harvard Medical School
Downloads 64 (545,079)

Abstract:

Loading...

drugs, efficacy, evidence-based medicine, FDA, pharmaceutical policy

18.

Beating the Bluebook Blues: A Response to Judge Posner

Michigan Law Review First Impressions, Vol. 109, No. 92
Number of pages: 7 Posted: 04 May 2012
Stephen Darrow and Jonathan J. Darrow
Harvard University and Harvard Medical School
Downloads 58 (572,102)

Abstract:

Loading...

Bluebook, Posner, subciting, citation, legal citation

19.

The Question Remains after Raytheon Co. v. Hernandez: Whether No Rehire Rules Disparately Impact Alcoholics and Former Drug Abusers

U. Penn. J. Labor & Emp. L., 2004
Number of pages: 17 Posted: 03 May 2012
Christine Neylon O'Brien and Jonathan J. Darrow
Boston College - Carroll School of Management and Harvard Medical School
Downloads 41 (662,394)

Abstract:

Loading...

20.

Designing Development Programs for Non-Traditional Antibacterial Agents

Nature Communications (2019) 10:3416 DOI: 10.1038/s41467-019-11303-9, Boston Univ. School of Law, Public Law Research Paper No. #19-17 (2019)
Number of pages: 11 Posted: 24 Sep 2019
John H. Rex, Holly Fernandez Lynch, I. Glenn Cohen, Jonathan J. Darrow and Kevin Outterson
F2G Limited, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Harvard Law School, Harvard Medical School and Boston University School of Law
Downloads 35 (707,087)
Citation 1

Abstract:

Loading...

antibacterial resistance, antibacterial agents

21.

The Patent Trial and Appeal Board - A Second Constitutional Challenge

Number of pages: 11 Posted: 18 Nov 2021
Gregory Curfman and Jonathan J. Darrow
American Medical Association and Harvard Medical School
Downloads 25 (772,732)

Abstract:

Loading...

22.

Federal Circuit Review of USPTO Inter Partes Review Decisions, by the Numbers: How the AIA Has Impacted the Caseload of the Federal Circuit

98 J. Pat. & Trademark Off. Soc’y 105 (2016)
Number of pages: 15 Posted: 13 Nov 2019
Evan J. Wallach and Jonathan J. Darrow
affiliation not provided to SSRN and Harvard Medical School
Downloads 25 (772,732)
Citation 2

Abstract:

Loading...

IPR, inter partes review, USPTO, patent, AIA

23.

A New Wave of Vaccines for Non-Communicable Diseases: What Are the Regulatory Challenges?

70(2) Food Drug Law J. 243 (2015)
Number of pages: 17 Posted: 13 Nov 2019
Jonathan J. Darrow
Harvard Medical School
Downloads 24 (780,696)

Abstract:

Loading...

24.

At $28,000 a Dose, How Effective Is Acthar?

Bill of Health (Harvard), 2013
Number of pages: 4 Posted: 14 Nov 2019
Jonathan J. Darrow
Harvard Medical School
Downloads 22 (796,794)

Abstract:

Loading...

25.

A New Approach to Treat Childhood Leukemia: Novartis’ CAR-T Therapy

45 JOURNAL OF LAW MEDICINE & ETHICS 692 (2018)
Number of pages: 12 Posted: 23 Aug 2019
Frazer Tessema and Jonathan J. Darrow
Harvard University - Brigham and Women's Hospital and Harvard Medical School
Downloads 18 (830,965)
Citation 1

Abstract:

Loading...

CAR-T, gene therapy, cancer, efficacy, FDA, drug

26.

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Downloads 0 (982,410)

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol. 37, No. 1, 03.01.2019, p. 21-22.
Posted: 24 Apr 2019
Timo Minssen, Aaron S. Kesselheim and Jonathan J. Darrow
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol.37, No. 1, pp. 21-22 (2019); DOI: 10.1038/nbt.4324
Posted: 27 Jun 2019
Timo Minssen, Aaron S. Kesselheim and Jonathan J. Darrow
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

Other Papers (2)

Total Downloads: 51
Actions:
Email selected abstracts
1.

Xolair for Chronic Itch: Magic Bullet or Marketing Hype?

Bill of Health Blog, February 2013
Number of pages: 3 Posted: 13 Nov 2013
Jonathan J. Darrow
Harvard Medical School
Downloads 26

Abstract:

Loading...

Xolair, omalizumab, hives, FDA, NEJM, placebo, ethics

2.

The High Cost of Health Care: Why Some Pay $240 for a $9 Bottle of Pills

Bill of Health Blog, February 2013
Number of pages: 4 Posted: 13 Nov 2013
Jonathan J. Darrow
Harvard Medical School
Downloads 25

Abstract:

Loading...

health care, cost, prescription, drugs, finasteride, Wal-Mart, generics, alopecia, Proscar